Response endures in cemiplimab-treated patients with cutaneous SCCJune 14, 2019Nonmelanoma Skin Cancer
Advanced basal cell carcinoma responds to pembrolizumab in proof-of-concept studyJune 13, 2019Nonmelanoma Skin Cancer
Study finds inconsistent links with aspirin, nonaspirin NSAIDs and reduced skin cancer riskMay 28, 2019Nonmelanoma Skin CancerPreventive CareHead & Neck/Thyroid Cancers
Baseline imaging recommended in all Merkel cell carcinoma patientsMay 13, 2019Nonmelanoma Skin CancerRare Diseases
Atypical case of cutaneous MCL mimics SPTCLMay 10, 2019Lymphoma & Plasma Cell DisordersNonmelanoma Skin Cancer
Ultrasound offers advantages for long-term lymph node surveillance in high-grade SCC patientsMay 8, 2019Nonmelanoma Skin CancerHead & Neck/Thyroid Cancers
Dr. Douglas Paauw gives updates on antihypertensives, statins, SGLT2 inhibitorsApril 19, 2019Lung CancerNonmelanoma Skin Cancer
CLL, GVHD may raise risk for skin cancer after allo-HCTFebruary 28, 2019Nonmelanoma Skin CancerLeukemia, Myelodysplasia, Transplantation
BCL expression intensity key in distinguishing FL lesionsFebruary 10, 2019Lymphoma & Plasma Cell DisordersFollicular LymphomaNonmelanoma Skin Cancer
Increased risk of second cancers in mycosis fungoidesFebruary 8, 2019Lymphoma & Plasma Cell DisordersNonmelanoma Skin Cancer
Cerdulatinib yields ‘encouraging’ results in CTCL, PTCLFebruary 6, 2019Lymphoma & Plasma Cell DisordersNonmelanoma Skin Cancer
IPH4102 on fast track for Sézary syndromeJanuary 30, 2019Lymphoma & Plasma Cell DisordersNonmelanoma Skin Cancer
FDA approves cemiplimab for advanced cutaneous squamous cell carcinomaSeptember 29, 2018Nonmelanoma Skin Cancer
Skin signs may be good omens during cancer therapySeptember 13, 2018Nonmelanoma Skin CancerImmuno-oncologyPatient & Survivor CareMelanoma
